Prevalence of smoldering multiple myeloma based on nationwide screening.

导出 OA

翻译打印收藏纠错

第一作者： Sigrún,Thorsteinsdóttir

第一单位： Faculty of Medicine, University of Iceland, Reykjavík, Iceland.

作者： Sigrún,Thorsteinsdóttir ^[1] ; Gauti K,Gíslason ^[2] ; Thor,Aspelund ^[1] ; Sæmundur,Rögnvaldsson ^[3] ; Jón Þórir,Óskarsson ^[1] ; Guðrún Á,Sigurðardóttir ^[1] ; Ásdís R,Þórðardóttir ^[1] ; Brynjar,Viðarsson ^[1] ; Páll T,Önundarson ^[4] ; Bjarni A,Agnarsson ^[4] ; Margrét,Sigurðardóttir ^[4] ; Ingunn,Þorsteinsdóttir ^[4] ; Ísleifur,Ólafsson ^[4] ; Elías,Eyþórsson ^[4] ; Ásbjörn,Jónsson ^[4] ; Oscar,Berlanga ^[4] ; Malin,Hultcrantz ^[5] ; Brian G M,Durie ^[6] ; Thorvardur J,Löve ^[7] ; Stephen,Harding ^[1] ; Ola,Landgren ^[5] ; Sigurður Y,Kristinsson ^[8]

作者单位： Faculty of Medicine, University of Iceland, Reykjavík, Iceland. ^[1] Department of Hematology, Rigshospitalet, Copenhagen, Denmark. ^[2] Public Health Sciences, University of Iceland, Reykjavík, Iceland. ^[3] Landspítali University Hospital, Reykjavík, Iceland. ^[4] The Binding Site, Birmingham, UK. ^[5] Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[6] Cedars-Sinai Samual Oschin Cancer Center, Los Angeles, CA, USA. ^[7] Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. ^[8] Faculty of Medicine, University of Iceland, Reykjavík, Iceland. sigyngvi@hi.is. ^[9] Landspítali University Hospital, Reykjavík, Iceland. sigyngvi@hi.is. ^[10]